Voyager Therapeutics is trading 5.4% lower at $2.97 amid broader market weakness, as rising crude oil and Treasury yields pressure risk appetite.

  • The Nasdaq Composite is down 1.00%, while the S&P 500 is down 0.55%.
  • No fresh company-specific announcement, analyst action, filing, or clinical update was identified.
  • The latest investor event was the September 8 Wells Fargo healthcare conference.